HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tail stent versus re-entry tube: a randomized comparison after percutaneous stone extraction.

AbstractOBJECTIVES:
To evaluate the efficacy of a 7F tail stent with an 18F Councill nephrostomy tube and compare it to a 24F re-entry Malecot nephrostomy tube after percutaneous nephrolithotomy.
METHODS:
Forty patients were prospectively randomized to receive either a 24F re-entry Malecot nephrostomy tube (group A, n = 20) or a 7F tail stent with an 18F Councill nephrostomy tube (group B, n = 20) for postoperative drainage. Patients were evaluated with an analogue scale questionnaire 15 days after percutaneous nephrolithotomy at the routine office follow-up visit asking them to rate the flank pain on a 0 to 10 scale, urinary urgency on a 0 to 10 scale, and quality of life, while the external drainage tubes were still in place.
RESULTS:
The mean length of stay was 4.5 and 3.5 days for groups A and B, respectively. Flank urine leakage was present in all patients in group A for a period of 6 to 12 hours, and no patient in group B had any significant flank drainage. A statistically significant reduction of flank pain in favor of group B was observed (P = 0.0002). We did not observe any statistically significant difference when evaluating the urgency (P = 0.1) and quality-of-life scores (P = 0.09) between the two groups, even though a trend was noted toward amelioration in favor of group B patients.
CONCLUSIONS:
The results of the present study suggest that the 7F tail stent is certainly better tolerated by the patients after percutaneous nephrolithotomy compared with the standard 24F re-entry Malecot nephrostomy tube.
AuthorsEvangelos N Liatsikos, David Hom, Caner Z Dinlenc, Rakesh Kapoor, Mihai Alexianu, Paulos Yohannes, Arthur D Smith
JournalUrology (Urology) Vol. 59 Issue 1 Pg. 15-9 (Jan 2002) ISSN: 1527-9995 [Electronic] United States
PMID11796272 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Topics
  • Drainage (instrumentation)
  • Follow-Up Studies
  • Humans
  • Length of Stay
  • Nephrostomy, Percutaneous (instrumentation)
  • Pain, Postoperative (prevention & control)
  • Prospective Studies
  • Quality of Life
  • Stents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: